Minireviews
Copyright ©The Author(s) 2017.
World J Clin Oncol. Dec 10, 2017; 8(6): 429-436
Published online Dec 10, 2017. doi: 10.5306/wjco.v8.i6.429
Table 1 Age-adjusted hepatocellular carcinoma incidence and liver cancer mortality rates per 100000 persons, 2006-2010[5]
OutcomeAge (yr)All races
None-hispanic
Hispanic
White
Black
API
Rate95%CIRate95%CIRate95%CIRate95%CIRate95%CI
HCCOverall5.9(5.8-5.9)4.2(4.2-4.3)7.5(7.3-7.8)11.7(11.3-12.0)9.5(9.3-9.8)
Incidence35-492.2(2.1-2.3)1.4(1.3-1.5)2.5(2.2-2.8)4.7(4.3-5.2)3.2(2.9-3.4)
SEER 1850-6416.5(16.2-16.8)12.2(11.9-12.6)26.9(25.8-28.1)23.5(22.4-24.7)24.3(23.3-25.3)
> 6522.3(21.9-22.7)16.0(15.5-16.4)22.4(20.9-23.9)54.7(52.4-57.0)40.5(38.7-42.4)
Liver cancerOverall4.3(4.3-4.3)3.6(3.5-3.6)6.4(6.3-6.6)8.2(7.9-8.4)7.0(6.9-7.2)
Mortality35-491.2(1.2-1.2)0.9(0.8-0.9)2.0(1.9-2.2)2.8(2.6-3.1)1.4(1.3-1.5)
US50-649.7(9.5-9.8)7.7(7.6-7.8)18.6(18.2-19.1)13.0(12.4-13.6)13.5(13.0-13.9)
> 6520.1(19.9-20.3)17.2(17.0-17.5)24.5(23.7-25.3)43.2(41.6-44.8)36.7(35.6-37.8)